Cypher TLR Reduction Maintained In Diabetics – Sabaté’s Study

Spanish trial data on J&J/Cordis' Cypher sirolimus-eluting stent in diabetics are "a good starting position" to approach FDA about a labeling claim to benefit this treatment population, VP-Clinical & Regulatory Affairs Dennis Donohoe, MD, said Sept. 28